NextVision Sets Pricing for Global Offering of Ordinary Shares Raising Approximately $413.7 Million
On September 16, 2025, Next Vision Stabilized Systems Ltd. (TASE: NXSN), a pioneering company in stabilized imaging solutions for both ground and aerial platforms, announced the pricing of its global offering of ordinary shares. This offering is directed towards institutional investors both in Israel and internationally, comprising a total of 9,500,000 ordinary shares priced at NIS 146 each. This move is projected to generate approximately NIS 1,387,000,000 (around $413.7 million) in gross proceeds, which NextVision intends to allocate toward strategic growth initiatives.
The primary objective of this capital influx is to fund various endeavors that are critical to the company’s advancement. These initiatives include exploring potential mergers and acquisitions aligned with NextVision's core operational focuses, enhancing its research and development projects, and meeting general working capital needs. This offering will settle on September 17, 2025, subject to customary closing conditions, and shares are expected to start trading on the Tel-Aviv Stock Exchange on September 18, 2025.
NextVision's decision to pursue this global offering comes during a period of expansion for the company. Recognized for its advanced imaging technologies, NextVision develops, manufactures, and markets stabilized day and night imaging capabilities for a variety of applications, primarily in defense, civil, and commercial sectors. The company’s products are crucial for unmanned aerial vehicles (UAVs) and drones, making it a vital player in the rapidly evolving market of aerial technology.
Jefferies serves as the Sole Global Coordinator for this offering, with Leader acting as Local Coordinator, ensuring a seamless process as the company embarks on this financial maneuver. Although the offering is set against a backdrop of robust market interest in aerospace and defense technologies, it is crucial to understand that this announcement is not an offer to sell any securities and does not solicit any purchase in jurisdictions where such offers would be unlawful.
NextVision emphasizes that the securities involved in this transaction have not been registered under the U.S. Securities Act of 1933, and as such, will only be available to qualified institutional buyers as defined by relevant regulations. For international investments, the offering adheres to Regulation S of the Securities Act.
As with any investment opportunity, potential investors are reminded of the inherent risks involved. While NextVision's advancements and the increasing demand for reliable imaging technologies present attractive opportunities, investors must conduct due diligence, weighing individual circumstances before making investment decisions. The company's forward-looking statements, including predictions and assumptions about financial performance and growth prospects, are based on current information available at the time of this announcement and should be approached with cautious optimism due to various external factors that could influence future outcomes.
In summary, the pricing of NextVision's global offering marks a significant milestone in its growth trajectory, aiming to bolster its position in the market. With a robust plan to utilize the expected gains for strategic purposes, the company is poised to navigate the industry's challenges and seize opportunities ahead, with a focus on continual innovation in imaging solutions.